Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats.
Ghule, Arvindkumar E
Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats. [electronic resource] - International immunopharmacology Dec 2012 - 740-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-1705
10.1016/j.intimp.2012.10.004 doi
Alkaloids--pharmacology
Animals
Animals, Newborn
Apoptosis--drug effects
Blood Glucose
Diabetes Mellitus, Experimental--blood
Diabetic Nephropathies--drug therapy
Fibrosis--drug therapy
Hypoglycemic Agents--pharmacology
Insulin--blood
Kidney--cytology
Oxidative Stress--drug effects
Rats
Rats, Wistar
Trigonelline ameliorates diabetic hypertensive nephropathy by suppression of oxidative stress in kidney and reduction in renal cell apoptosis and fibrosis in streptozotocin induced neonatal diabetic (nSTZ) rats. [electronic resource] - International immunopharmacology Dec 2012 - 740-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1878-1705
10.1016/j.intimp.2012.10.004 doi
Alkaloids--pharmacology
Animals
Animals, Newborn
Apoptosis--drug effects
Blood Glucose
Diabetes Mellitus, Experimental--blood
Diabetic Nephropathies--drug therapy
Fibrosis--drug therapy
Hypoglycemic Agents--pharmacology
Insulin--blood
Kidney--cytology
Oxidative Stress--drug effects
Rats
Rats, Wistar